Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05037682 · ClinicalTrials.gov registry record · NA

Pain and Opioid Management in Older Adults

A NA study of Opioid Use Disorder and Pain, Chronic, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
1,035
Enrollment target
1
Study location

NCT05037682: Recruiting NA study of Opioid Use Disorder and Pain, Chronic, sponsored by University of Oklahoma.

NCT05037682 is a NA study of Opioid Use Disorder and Pain, Chronic that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 1,035 participants, below the 4,652-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05037682, a NA study of Opioid Use Disorder and Pain, Chronic, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
1,035 participants
Enrollment target
1
Study location

Study Summary

The extent and depth of the ongoing opioid crisis are well known and many interventions are under way in the United States and other countries to alleviate its devastating impact on individuals and the society. To address specific challenges of pain and opioid management (POM) in older and vulnerable adults, the investigators will design and implement a multi-faceted, person-centered, and scalable opioid use disorder (OUD) management program in Oklahoma primary care practices. The investigators expect that the rigorously designed and evidence-based program will establish and disseminate innovative solutions for pain and opioid management in high-risk, older and vulnerable populations living with chronic pain. The proposed initiative will help primary care practices optimize pain management approaches in older adults through an integrated and trans-disciplinary application of innovations in multi-modal pain management, pain mechanism-based pharmacotherapy, patient goal-oriented care, implementation science, evidence-based quality improvement methodology, and community-engaged design.

Interventions

  • OTHER Dissemination and Implementation Research

Study Locations (1)

Oklahoma

  • Oklahoma Clinical and Translational Science Institute - Oklahoma City

Trial Details

FieldValue
Enrollment Target 1,035 participants
Start Date 2020-09-30
Est. Completion 2024-09-30
Phase NA
University of Oklahoma

358 total trials

What NCT05037682 shows while recruiting

NCT05037682 is an interventional study that assigns participants to a tested intervention. Its 1,035 participants enrollment target places it among the larger protocols in the corpus, below the 4,652-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Dissemination and Implementation Research is the first listed.

NCT05037682 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05037682 about?

NCT05037682 is a clinical study titled "Pain and Opioid Management in Older Adults". The extent and depth of the ongoing opioid crisis are well known and many interventions are under way in the United States and other countries to alleviate its devastating impact on individuals and the society. To address specific challenges of pain and opioid management (POM) in older and vulnerabl...

What is the current status of trial NCT05037682?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,035 participants. The study started on 2020-09-30. Estimated completion is 2024-09-30.

What conditions does trial NCT05037682 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Pain, Chronic.

What interventions are being tested in trial NCT05037682?

The interventions under investigation include: Dissemination and Implementation Research (OTHER).

Who is sponsoring clinical trial NCT05037682?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05037682 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05037682's enrollment target sits among peer trials

1,035 17th of 257 higher than 241 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07282600 · 1,035 participants · Phase 3

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • NCT07345767 · 1,038 participants · NA

    Hypknowledge Nationwide Sleep Extension

  • NCT07084363 · 1,032 participants · NA

    Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

  • NCT05219110 · 1,040 participants · NA

    Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05037682, the US trial registry maintained by the National Library of Medicine. NCT05037682 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.